HNF1B and ovarian carcinoma: It was demonstrated that shRNA mediated downregulation of HNF1B sensitizes ovarian cancer cells to cisplatin- or paclitaxel-mediated cytotoxicity, through inverse regulation of HSulf1 expression [27].